Caris Life Sciences, Inc. is 3.1x more valuable than Fortrea Holdings Inc. by market capitalization ($4.85 B vs $1.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FTRE | CAI |
|---|---|---|
| Market cap | $1.58 B | $4.85 B |
| US-listed rank | #2284 | #1404 |
| Revenue (latest FY) | $2.72B | $812.03M |
| Net income (latest FY) | -$989.00M | -$68.09M |
| Net margin | -36.3% | -8.4% |
| SEC filings | 294 | 102 |
Caris Life Sciences, Inc. is 3.1x more valuable than Fortrea Holdings Inc. by market capitalization ($4.85 B vs $1.58 B).
In their latest fiscal years, Fortrea Holdings Inc. reported $2.72B in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: Fortrea Holdings Inc. and Caris Life Sciences, Inc., or browse the full rankings.